The outbreak of the pandemic caused by the new coronavirus since the beginning of 2020 has reminded us how important it is to develop and research vaccines and therapeutic agents, and to respond to contingencies, from infectious disease control to immunization programs.
In this context, The Institute of Medical Science, The University of Tokyo (IMSUT), in collaboration with the Institut Pasteur of France, will hold a seminar (100% online format) to overview the current status, challenges, and prospects of new infection prevention through new modalities such as mRNA vaccines and crisis response by medical administration, among the disruptive innovations that occurred during the corona disaster.
The seminar will feature leading researchers from Japan and abroad, including Prof. Drew Weissman (U Penn), a pioneer in mRNA vaccine development and research, and Prof. Yasuhiro Suzuki, Vice President of the International University of Health and Welfare (former Vice-Minister & Chief Medical Officer of the Ministry of Health, Labour and Welfare), who was involved in Japan's medical crisis response. The panel discussion will be open to the public.
15:00-15:05 Opening remarks 1: Dr. Yuji YAMANASHI, Dean and Professor, The Institute of Medical Science, The University of Tokyo (IMSUT)
15:05-15:10 Opening remarks 2: Dr. Stewart COLE
15:10-15:40 Lecture 1: Dr. Ken ISHII, Professor, Division of Vaccine Science, Department of Microbiology and Immunology (IMSUT): "History of Vaccine Development and Trends in Domestic RNA Vaccines"
15:40-16:10 Lecture 2: Dr. Drew WEISSMAN (video), Professor, University of Pennsylvania (recorded appearance): "Development of mRNA Vaccines (tentative title)"
16:10-16:30 Lecture 3: Dr. Mohamad=Gabriel Alameh, Fellow, University of Pennsylvania: "Immunogenicity and protection of the mRNA-LNP platform in young versus aged animals"
16:30-16:50 Lecture 4: Dr. James Di Santo, Professor, Head of Innate Immunity Unit, The Institut Pasteur: "Distinct systemic and mucosal immune responses to SARS-COV-2"
（break 10 minutes）
17:00-17:20 Lecture 5: Dr. Teruhito Yasui, Project Leader, Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health, and Nutrition=NIBIOHN: "Therapeutic strategy for infectious diseases through antibody-based biologics - discovery, optimization and modality"
17:20-17:35 Lecture 6: Mr. Hisato Doi, President and Representative Director of EVEC, Inc.: "Role of human peripheral blood-derived antibodies in the treatment and prevention of COVID-19"
17:35-17:55 Lecture 7: Dr. Hugo Mouquet, Head of Humoral Immunity Unit, The Institut Pasteur: "Potent and Broad Human Antiviral IgA Monoclonal Antibodies"
17:55-18:15 Lecture 8: Prof. Yasuhiro Suzuki, Vice President, International University of Health and Welfare (former Vice-Minister & Chief Medical Officer of the Ministry of Health, Labour and Welfare): "The Truth about the "Vaccine Defeat": for avoiding the same mistake"
18:15-18:55 Panel Discussion
Moderator: Dr. Ken ISHII
Panelists: Dr. ALAMEH, Mr. DOI, Dr. SUZUKI, Dr. DI SANTO, Mr. OCHIAI (EFPIA Japan), Dr. Fumihiko MATSUDA (Director and Professor, The Center for Genomic Medicine, Kyoto University Graduate School of Medicine), Dr. Anavaj SAKUNTABHAI (Professor, Director, The Institut Pasteur Japan Office)
18:55-19:00 Closing remarks
Notice of the seminar on "Preventing Infectious Diseases with Novel Modalities" on Tuesday, October 19
|Date and Time||Oct. 19 [Tue] , 2021 15: 00-19：00 (JST)|
|Venue||VenueZoom webinar *For those who are unable to watch the webinar on the day, we will also be streaming it on YouTube at a later date.|
|Language||English/Japanese simultaneous translation|
|Additional Information||For details/applications, please visit the site below.
Organizers： Jointly organized by The Institute of Medical Science, The University of Tokyo (IMSUT), and the Institut Pasteur
Co-organizer： IMSUT as "International Joint Usage/Research Center"
Patronage： National Center for Global Health and Medicine
Secretariat：Fondation Pasteur Japon
Moderator： Prof. Ken Ishii, Division of Vaccine Science, Department of Microbiology and Immunology, IMSUT